DIFFERENCES IN RELEASE OF TUMOR-NECROSIS-FACTOR FROM THP-1 CELLS STIMULATED BY FILTRATES OF ANTIBIOTIC-KILLED ESCHERICHIA-COLI

被引:71
作者
SIMON, DM
KOENIG, G
TRENHOLME, GM
机构
[1] Department of Medicine, Section of Infectious Disease, Rush-Presbyt.-St. Luke's Med. Center, Chicago, IL
[2] Section of Infectious Disease, Rush-Presbyt.-St. Luke's Med. Center, AcFac, Chicago, IL 60612
关键词
D O I
10.1093/infdis/164.4.800
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bacterial products, such as endotoxin, activate mononuclear cells to produce tumor necrosis factor (TNF) and other monokines capable of producing host cell injury. THP-1 cell TNF release in response to bacterial products generated during antibiotic killing of Escherichia coli (ATCC 12014) was evaluated. THP-1 is a mature monocytic leukemia cell line that produces TNF in a dose-dependent fashion in response to purified endotoxin. E. coli were incubated in the presence of amikacin, ciprofloxacin, ceftazidime, cefotaxime, aztreonam, or imipenem at concentrations that killed > 99.9% of the organisms. Aliquots of these antibiotic-bacterial cultures were added to THP-1 cells, and TNF concentrations were determined by specific immunoassay. Amikacin and imipenem produced rapid bacterial killing and were associated with low TNF levels. Ceftazidime, aztreonam, and cefotaxime killed E. coli at a slower rate and were associated with significant increases in mononuclear cell TNF responses. Ciprofloxacin produced intermediate TNF levels. Differences exist among bactericidal antibiotics in their ability to generate products capable of stimulating mononuclear cell TNF release.
引用
收藏
页码:800 / 802
页数:3
相关论文
共 15 条
[1]  
ANDERSEN BM, 1980, ACTA PATH MICRO IM B, V88, P231
[2]  
BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[3]   LIPOPOLYSACCHARIDE (LPS)-REACTIVE MONOCLONAL-ANTIBODIES FAIL TO INHIBIT LPS-INDUCED TUMOR NECROSIS FACTOR SECRETION BY MOUSE-DERIVED MACROPHAGES [J].
CHIA, JKS ;
POLLACK, M ;
GUELDE, G ;
KOLES, NL ;
MILLER, M ;
EVANS, ME .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (05) :872-880
[4]  
GOTO H, 1980, JPN J EXP MED, V50, P35
[5]   TUMOR NECROSIS FACTOR AND DISEASE SEVERITY IN CHILDREN WITH FALCIPARUM-MALARIA [J].
GRAU, GE ;
TAYLOR, TE ;
MOLYNEUX, ME ;
WIRIMA, JJ ;
VASSALLI, P ;
HOMMEL, M ;
LAMBERT, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (24) :1586-1591
[6]  
HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147
[7]   PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN 1-BETA BY MONOCYTIC CELLS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS [J].
MOLINA, JM ;
SCADDEN, DT ;
BYRN, R ;
DINARELLO, CA ;
GROOPMAN, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (03) :733-737
[8]   MODULATION OF INFLAMMATION AND CACHECTIN ACTIVITY IN RELATION TO TREATMENT OF EXPERIMENTAL HEMOPHILUS-INFLUENZAE TYPE-B MENINGITIS [J].
MUSTAFA, MM ;
RAMILO, O ;
MERTSOLA, J ;
RISSER, RC ;
BEUTLER, B ;
HANSEN, EJ ;
MCCRACKEN, GH .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (05) :818-825
[9]   EFFICACY OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST TUMOR-NECROSIS-FACTOR IN PROTECTING NEUTROPENIC RATS FROM LETHAL INFECTION WITH PSEUDOMONAS-AERUGINOSA [J].
OPAL, SM ;
CROSS, AS ;
KELLY, NM ;
SADOFF, JC ;
BODMER, MW ;
PALARDY, JE ;
VICTOR, GH .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (06) :1148-1152
[10]   KINETICS OF ENDOTOXIN RELEASE DURING ANTIBIOTIC-THERAPY FOR EXPERIMENTAL GRAM-NEGATIVE BACTERIAL SEPSIS [J].
SHENEP, JL ;
MOGAN, KA .
JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (03) :380-388